These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15055526)

  • 1. NS398 inhibits the growth of Hep3B human hepatocellular carcinoma cells via caspase-independent apoptosis.
    Park MK; Hwang SY; Kim JO; Kwack MH; Kim JC; Kim MK; Sung YK
    Mol Cells; 2004 Feb; 17(1):45-50. PubMed ID: 15055526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
    Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis.
    Schmidt CM; Wang Y; Wiesenauer C
    J Gastrointest Surg; 2003 Dec; 7(8):1024-33. PubMed ID: 14675712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
    Fantappiè O; Solazzo M; Lasagna N; Platini F; Tessitore L; Mazzanti R
    Cancer Res; 2007 May; 67(10):4915-23. PubMed ID: 17510421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
    Kern MA; Haugg AM; Koch AF; Schilling T; Breuhahn K; Walczak H; Fleischer B; Trautwein C; Michalski C; Schulze-Bergkamen H; Friess H; Stremmel W; Krammer PH; Schirmacher P; Müller M
    Cancer Res; 2006 Jul; 66(14):7059-66. PubMed ID: 16849551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silibinin efficacy against human hepatocellular carcinoma.
    Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
    Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
    Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
    BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in human hepatoma cells by mycelia of Antrodia camphorata in submerged culture.
    Song TY; Hsu SL; Yen GC
    J Ethnopharmacol; 2005 Aug; 100(1-2):158-67. PubMed ID: 15949907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line.
    Chang J; Hsu Y; Kuo P; Kuo Y; Chiang L; Lin C
    Life Sci; 2005 Mar; 76(16):1883-93. PubMed ID: 15698865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of betulin against cadmium-induced apoptosis in hepatoma cells.
    Oh SH; Choi JE; Lim SC
    Toxicology; 2006 Mar; 220(1):1-12. PubMed ID: 16436312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells.
    Chang HC; Weng CF
    Oncol Rep; 2001; 8(6):1321-5. PubMed ID: 11605058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis.
    Okano J; Nagahara T; Matsumoto K; Murawaki Y
    Oncol Rep; 2007 May; 17(5):1195-200. PubMed ID: 17390065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells.
    Simbula G; Columbano A; Ledda-Columbano GM; Sanna L; Deidda M; Diana A; Pibiri M
    Apoptosis; 2007 Jan; 12(1):113-23. PubMed ID: 17136495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
    J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.